发明名称 1-CYCLOPROPYL-6-FLUORO-7-(8-METHOXYIMINO-2,6-DIAZA-SPIRO[3,4]OCT-6-YL)-4-OXO-1,4-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID D-ASPARTATE HYDRATES AND AN ANTIBACTERIAL PHARMACEUTICAL COMPOSITIONS COMPRISING THEIR HYDRATES
摘要 The present invention relates to 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3,4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid D-aspartate hydrates and an antibacterial composition comprising their hydrates. The present invention provides stable zabofloxacin D-aspartate hydrates wherein adsorption and desorption of water hardly occur, and provides specifically zabofloxacin D-aspartate sesquihydrate. Because the zabofloxacin D-aspartate hydrates according to the present invention hardly absorb moisture, they have an outstanding physicochemical property. Therefore, the drugs comprising zabofloxacin D-aspartate hydrate of the present invention do not easily break, especially in its tablet form, and changes little in the content of the main ingredient, thus exhibiting an excellent pharmaceutical stability.
申请公布号 WO2015133803(A1) 申请公布日期 2015.09.11
申请号 WO2015KR02065 申请日期 2015.03.04
申请人 DONG WHA PHARM. CO., LTD. 发明人 CHOI, DONG-RACK;LIM, JAE-KYUNG;CHANG, HWAN-BONG;BAEK, NAM-HYUN;KIM, SEUNG-HWAN;KIM, GUN-GOOK
分类号 C07D487/10;A61K31/4375;A61P31/04;C07D471/04 主分类号 C07D487/10
代理机构 代理人
主权项
地址